We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.77B
AUM Growth
+$335M
(+5.2%)
Cap. Flow
-$701M
Cap. Flow
% of AUM
-10.36%
Top 10 Holdings %
Top 10 Hldgs %
27.24%
Holding
1,412
New
326
Increased
336
Reduced
315
Closed
394
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$112M |
| 2 |
Labcorp
LH
|
+$102M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$70.5M |
| 4 |
CONMED
CNMD
|
+$63.7M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
+$49.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$234M |
| 2 |
AGN
Allergan plc
AGN
|
+$196M |
| 3 |
Cardinal Health
CAH
|
+$121M |
| 4 |
Tenet Healthcare
THC
|
+$74.9M |
| 5 |
MetLife
MET
|
+$71.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.81% |
| 2 | Energy | 7.28% |
| 3 | Consumer Discretionary | 5.8% |
| 4 | Financials | 4% |
| 5 | Technology | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Enviri
NVRI
$624M
| $218K | ﹤0.01% |
+10,175
| New | +$252K |
|
952
Norwegian Cruise Line
NCLH
$8.59B
| $217K | ﹤0.01% |
+6,020
| New | +$204K |
|
|
TGI
953
DELISTED
Triumph Group
TGI
| $217K | ﹤0.01% |
3,340
-2,191
| -40% | -$147K |
|
|
RKT
954
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $217K | ﹤0.01% |
4,557
-7,427
| -62% | -$369K |
|
955
PPG Industries
PPG
$25B
| $216K | ﹤0.01% |
2,200
-8,508
| -79% | -$867K |
|
|
BCR
956
DELISTED
CR Bard Inc.
BCR
| $214K | ﹤0.01% |
+1,500
| New | +$222K |
|
957
Bankunited
BKU
$3.33B
| $213K | ﹤0.01% |
7,000
-3,214
| -31% | -$102K |
|
958
Boyd Gaming
BYD
$6.47B
| $213K | ﹤0.01% |
+20,931
| New | +$227K |
|
959
F5
FFIV
$22.1B
| $212K | ﹤0.01% |
1,788
-4,825
| -73% | -$567K |
|
|
ACH
960
Accendra Health
ACH
$256M
| $211K | ﹤0.01% |
+6,443
| New | +$219K |
|
961
Tidewater
TDW
$3.65B
| $209K | ﹤0.01% |
166
-24
| -13% | -$37.5K |
|
|
SEE
962
DELISTED
Sealed Air
SEE
| $207K | ﹤0.01% |
5,945
-46,434
| -89% | -$1.61M |
|
|
VRE
963
DELISTED
Veris Residential
VRE
| $207K | ﹤0.01% |
10,819
-6,004
| -36% | -$125K |
|
964
Clear Channel Outdoor Holdings
CCO
$1.23B
| $206K | ﹤0.01% |
+30,600
| New | +$224K |
|
965
Commercial Metals
CMC
$7.57B
| $206K | ﹤0.01% |
12,048
-907
| -7% | -$15.9K |
|
966
Trinity Industries
TRN
$2.73B
| $206K | ﹤0.01% |
6,112
-89,390
| -94% | -$2.96M |
|
|
EQY
967
DELISTED
Equity One
EQY
| $206K | ﹤0.01% |
+9,516
| New | +$222K |
|
968
Intel
INTC
$460B
| $205K | ﹤0.01% |
+5,900
| New | +$200K |
|
|
WR
969
DELISTED
Westar Energy Inc
WR
| $205K | ﹤0.01% |
6,014
-141,976
| -96% | -$5.14M |
|
970
Evercore
EVR
$12.1B
| $204K | ﹤0.01% |
4,344
-2,884
| -40% | -$149K |
|
971
Best Buy
BBY
$18.5B
| $202K | ﹤0.01% |
+6,000
| New | +$188K |
|
972
Everest Group
EG
$14.9B
| $202K | ﹤0.01% |
+1,247
| New | +$202K |
|
973
Equinix
EQIX
$103B
| $202K | ﹤0.01% |
952
-485
| -34% | -$104K |
|
974
Align Technology
ALGN
$12.4B
| $201K | ﹤0.01% |
3,893
-169,397
| -98% | -$9.23M |
|
975
LiveRamp
RAMP
$2.3B
| $178K | ﹤0.01% |
+10,785
| New | +$203K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Visium Asset Management held 1,412 positions worth $6.77B, up 5.2% from $6.44B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Visium Asset Management withdrew a net $701M in Q3 2014, closing 394 positions and reducing 315 holdings. Its most notable exit was Pacira BioSciences, an estimated $40.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 50% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Visium Asset Management opened a new position in Liberty TripAdvisor Holdings, Inc. Series A worth $21.9M.
- Visium Asset Management's largest Q3 2014 buy was Liberty TripAdvisor Holdings, Inc. Series A: 646,673 shares worth $21.9M.
- Visium Asset Management added most to Elevance Health in Q3 2014, an estimated $112M increase.
- Visium Asset Management's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $234M.
- Visium Asset Management fully exited Pacira BioSciences in Q3 2014, selling an estimated $40.3M.
- Visium Asset Management's ten largest holdings make up 27% of its $6.77B portfolio in Q3 2014.
- Visium Asset Management opened 326 new positions and closed 394 in Q3 2014.
- Visium Asset Management's portfolio value rose 5.2% quarter-over-quarter to $6.77B.
Based on Visium Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.